Accendra Health, Inc. (ACH) vs Henry Schein, Inc. (HSIC)
Accendra Health, Inc. and Henry Schein, Inc. are both Medical Distribution companies. Henry Schein, Inc. is the larger, with a market value of $9.5B against $59.2M — 160.9× the size. Accendra Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Henry Schein, Inc. trades at 25.0×. Accendra Health, Inc. grew revenue faster over the last twelve months: 247.0% against 6.49%. Henry Schein, Inc. has the higher net margin (2.96% vs −11.4%) and the higher return on invested capital (6.97% vs 1.58%). Across the 19 metrics below, Henry Schein, Inc. leads on 11 and Accendra Health, Inc. on 8.
Valuation
Profitability
| Metric | ACH | HSIC | Medical Distribution median |
|---|---|---|---|
| Gross margin | 44.83% | 31.32% | 8.01% |
| Operating margin | 1.11% | 5.00% | 0.46% |
| Net margin | (11.41%) | 2.96% | (6.08%) |
| Free cash flow margin | (7.97%) | 4.18% | 0.00% |
| Return on equity | 72.63% | 10.20% | 0.00% |
| Return on assets | (9.65%) | 3.62% | 0.00% |
| Return on invested capital | 1.58% | 6.97% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack